A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

NCT06761417 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors
Children
Adolescents

Interventions

DRUG: Mitoxantrone liposome
DRUG: Capecitabine
DRUG: Anlotinib

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences